Boehringer Ingelheim Venture Fund Overview
- Fund Type
-
Venture
- Fund Status
-
Closed
- Fund Manager
- Boehringer Ingel...
- Size
-
$463M
- Vintage
-
2010
- Dry Powder
-
Boehringer Ingelheim Venture Fund General Information
Description
Boehringer Ingelheim Venture Fund is a venture capital fund managed by Boehringer Ingelheim Venture Fund. The fund is located in Maisons-Alfort, France, and invests in digital health, and pharmaceuticals and biotechnology. The fund invests between EUR 0.5 to EUR 15 million with an investment horizon of 5 to 7 years.
Contact Information
Fund Manager's Location
- Binger Straße 173
- 55216 Ingelheim am Rhein
- Germany
Boehringer Ingelheim Venture Fund Investments (31)
Boehringer Ingelheim Venture Fund has made a total of 31 investments. Its most recent deal was a with EvlaBio for . The deal was made on 07-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| EvlaBio | 07-Jul-2025 | Biotechnology | Generating Revenue | |||
| Refoxy Pharma | 04-Dec-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Synthetica (China) | 26-Jul-2024 | Biotechnology | Pre-Clinical Trials | |||
| Tacalyx | 11-Jun-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Asgard Therapeutics | 14-Mar-2024 | Biotechnology | Pre-Clinical Trials | |||
| Obulytix | 05-Dec-2023 | Biotechnology | Generating Revenue | |||
| Glox Therapeutics | 13-Nov-2023 | Drug Discovery | Startup | |||
| Smartbax | 23-May-2023 | Drug Discovery | Generating Revenue | |||
| Diogenx | 01-Mar-2023 | Early Stage VC (Series A) | Drug Discovery | Pre-Clinical Trials | ||
| C-mo Medical Solutions | 31-Jan-2023 | Seed Round | Monitoring Equipment | Generating Revenue |
Boehringer Ingelheim Venture Fund Investment Strategy
Investments by Industry
Investments by Deal Type
Boehringer Ingelheim Venture Fund Limited Partners (1)
Boehringer Ingelheim Venture Fund is the sole limited partner of Boehringer Ingelheim Venture Fund. Its latest Original was on 31-Dec-2010.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Boehringer Ingelheim Venture Fund | Current | 31-Dec-2010 | Original |
Boehringer Ingelheim Venture Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Boehringer Ingelheim Venture Fund Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Boehringer Ingelheim Venture Fund Benchmark (3)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| National Fund for Digital Society | |||||
| Accel London III | |||||
| Energy Ventures IV | 31-Dec-2024 |
Boehringer Ingelheim Venture Fund FAQs
-
What is Boehringer Ingelheim Venture Fund?
Boehringer Ingelheim Venture Fund is a venture capital fund managed by Boehringer Ingelheim Venture Fund.
-
Who manages Boehringer Ingelheim Venture Fund?
Boehringer Ingelheim Venture Fund is managed by Boehringer Ingelheim Venture Fund.
-
Where is Boehringer Ingelheim Venture Fund domiciled?
Boehringer Ingelheim Venture Fund is domiciled in Germany.
-
What is Boehringer Ingelheim Venture Fund's size?
Boehringer Ingelheim Venture Fund has a size of $463M.
-
What type of fund is Boehringer Ingelheim Venture Fund?
The fund type of Boehringer Ingelheim Venture Fund is Venture.
-
What is the status of Boehringer Ingelheim Venture Fund?
Boehringer Ingelheim Venture Fund is closed.
-
What has Boehringer Ingelheim Venture Fund invested in?
Boehringer Ingelheim Venture Fund has made numerous investments in companies like EvlaBio, Refoxy Pharma, and Synthetica (China) within the Biotechnology and Drug Discovery industries.
-
What has Boehringer Ingelheim Venture Fund invested in recently?
Boehringer Ingelheim Venture Fund's latest investment was on 07-Jul-2025 in EvlaBio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
